GENE ONLINE|News &
Opinion
Blog

Deals
Funding FDA
Nineteen Grants and Two Contracts Grab $38 Million In Support From the FDA
2022-10-17
Partnerships Bispecific Antibody
Gilead and MacroGenics Strike Potential $1.7 billion Collaboration Over Bispecific Antibodies
2022-10-17
M&A Novo Nordisk
Novo Nordisk Finally Finalizes their Billion Dollar Acquisition of Forma Therapeutics
2022-10-14
China WuXi Biologics
WuXi Biologics, Toregem BioPharma To Develop Tooth-Regenerating Antibody
2022-10-14
Partnerships Ginkgo Bioworks
Ginkgo Bioworks and Merck’s Collaboration Worth Up to $144 million
2022-10-13
Partnerships Keytruda
Moderna Gets $250 Million from MSD in Personal Cancer Vaccine Licensing Option
2022-10-12
Funding Funding
Andera Partners Drums Up $443 Million For Its Largest Life Sciences Fund
2022-10-11
Pfizer Opts In On Neurological Target In Voyager Deal, Leaving $290 Million In Milestones
2022-10-05
Partnerships Sanofi
Sanofi, miRecule To Develop Muscular Dystrophy Candidate In $400+ Million Partnership
2022-10-05
M&A Myovant
Myovant Turns Down $2.4 Billion Buyout Bid From Sumitomo
2022-10-03
M&A Alexion Pharmaceuticals
Alexion Snaps Up LogicBio Seeking Expansion into Genomic Medicines
2022-10-03
Licensing Novo Nordisk
Novo Nordisk Places $700 Million Bet on Ventus’ NLRP3 Inhibitor Program
2022-09-30
Funding Oncology
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Asia-Pacific siRNA
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Licensing Cancer
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
1 … 11 12 13 14 15 … 47
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top